Barclays analyst Peter Lawson raised the firm’s price target on Incyte (INCY) to $101 from $90 and keeps an Overweight rating on the shares post the Q3 report. The company offered a “solid” commercial update with product beats for Jakafi, Opzelura and continued momentum for Niktimvo launch, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INCY: